Cyclacel Pharmaceuticals , Inc. (NASDAQ:CYCC), a biopharmaceutical company with a market capitalization of just $1.92 million, has made significant changes to its corporate structure and shareholder ...

Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...